Stephen H. Culp, M.D., Ph.D. Assistant Professor, Department of Urology discusses Cytoreductive Nephrectomy at the Kidney Cancer Association meeting in…
Sarah P. Psutka MD Fellow in Urologic Oncology Mayo Clinic, Rochester, MN presents the Latest On IVC Tumor Thrombus at…
Jonathan Coleman, MD Memorial Sloan-Kettering Cancer Center Weill – Cornell University Medical College presents Kidney Cancer Management:The Role of Lymph…
At the iwNHL 2014, Prof Francesco D’Amore (Aarhus University, Aarhus, Denmark) interviews Dr Elaine Jaffe (National Cancer Institute, Maryland, USA)…
Thomas D. Atwell, MD presents Ablation of larger and recurrent tumors at the Kidney Cancer Association meeting in Chicago 2014
R. Houston Thompson, MD of the Mayo Clinic presents NCCN and AUA GUIDELINES FOR RCC: DO THEY EFFECTIVELY CAPTURE RECURRENCES…
Joel Prince of The University of Wisconsin School of Medicine and Public Health presents Patient and Tumor Characteristics Predict Indeterminate…
Jose A. Karam, MD Assistant Professor Department of Urology MD Anderson presents Locally Advanced RCC: Neoadjuvant Targeted Therapy
Tony Finelli MD, MSc, FRCSC GU Site Lead, Princess Margaret Cancer Center GU Lead, Cancer Care Ontario Associate Professor, University…
Lara Barbara – Breast Cancer Survivor NSHOA Treats Patients with Chemo and Hugs brought to you by The Community Oncology…
Michael Murray – Primary Goal for Everyone at NSHOA is Patient Care brought to you by The Community Oncology Alliance…
Dr. Ron Burkes commenting on the results of the Lux-Lung8 Trial from ESMO 2014
Dr. Natasha Leighl, lead study author, on the newsiest results on the activity of pembrolizumab in lung cancer
Dr. Edith Perez speaking on the expanded results of the ALTTO breast cancer trial
Dr. Sunil Verma providing a comprehensive update on the latest lung cancer updates from ESMO 2014
Don Marx – Care for Today, Research for Tomorrow brought to you by The Community Oncology Alliance (COA) and The…
Dr. Tewari at ESMO 2014 on latest advanced cervical cancer therapies
Dr. Teresa Petrella and Dr. Catalin Mihalcioiu speaking on combination therapies in melanoma.
Mark Levine – CFO North Shore Hematology Oncology Focused on Patient Care brought to you by The Community Oncology Alliance…
Immuno-Oncology: Shaping the Present, Transforming the Future and Raising the Bar in Oncology – from Best of ASCO Canada 2014
Nicole Gregory – The Chief Commercial Officer – What we do for our Patients brought to you by The Community…
Michael Mitrani – Guiding Patients Through the Benefits Maze brought to you by The Community Oncology Alliance (COA) and The…
Timothy A. Masterson, MD Assistant ProfessorDepartment of UrologyIndiana University Medical Center and Vitaly Margulis MD Associate Professor of Urology of…
Nicholas G. Cost, M.D.Assistant Professor, Department of Surgery, Division of Urology University of Colorado School of Medicine discusses Hereditary Syndromes…
Brian Shuch, MD Assistant Professor of Urology and Radiology Yale School of Medicine presents Management of Kidney Cancer in Young…
E. Jason Abel MD, FACS of the University of Wisconsin presents Renal mass biopsy for risk stratification in RCC: benefits…
Mark Purdue, PhDOntario Institute for Cancer Research discusses Epidemiology and Genomics of Renal Cell Carcinoma at the Kidney Cancer Association…
Projecting Individual Probability for Developing Renal Cell Cancer presented by Xifeng Wu, MD, PHD, Professor and ChairDepartment of Epidemiology Betty…
At the iwNHL 2014, Dr Rafael Fonseca (Mayo Clinic, Arizona, USA) interviews Prof Keith Stewart (Mayo Clinic, Arizona, USA) and…
At the iwNHL 2014, Prof John Gribben (Barts Cancer Institute, London, UK) interviews Prof Wolfram Brugger (University of Freiburg, Villingen-Schwenningen,…
At the iwNHL 2014, Dr Steven Rosen (City of Hope National Medical Center, California, USA) describes the progress made in…
At the iwNHL 2014, Dr Mathias Rummel (Justus-Liebig University-Hospital, Gießen, Germany) describes his research investigating the use of bendamustine plus…
At the iwNHL 2014, Prof John Gribben (Barts Cancer Institute, London, UK) interviews Prof Randy Gascoyne (British Columbia Cancer Agency,…
At the iwNHL 2014, Prof John Gribben (Barts Cancer Institute, London, UK) interviews Prof Randy Gascoyne (British Columbia Cancer Agency,…
At the iwNHL 2014, Prof John Gribben (Barts Cancer Institute, London, UK) interviews Prof Randy Gascoyne (British Columbia Cancer Agency,…
Prof John Gribben (Barts Cancer Institute, London, UK) chairs a discussion with Dr Wyndham Wilson (National Cancer Institute, Bethesda, USA),…
Prof John Gribben (Barts Cancer Institute, London, UK) chairs a discussion with Prof Randy Gascoyne (British Columbia Cancer Agency, Vancouver,…
At the iwNHL 2014, Prof Michael Pfreundschuh (Saarland University Medical School, Homburg, Germany), Dr Rich Fisher (Fox Chase Cancer Center,…
At the iwNHL 2014, Prof Susan OBrien (MD Anderson Cancer Center, Texas, USA) and Prof Eva Kimby (Karolinska Institutet, Huddinge,…
At ESMO 2014, Dr Jennifer Temel is interviewed about the results of a phase III trial investigating the use of…
At ESMO 2014, Prof Tony Mok presents the results of the IMPRESS trial. This phase III trial showed that continuation…
At ESMO 2014, Prof Sandra Swain presents the results of the CLEOPATRA trial. This phase III trial in patients with…
During a press conference at ESMO 2014, Prof Frédéric Amant, University of Leuven, Leuven, Belgium, discusses his study on the…
At ESMO 2014, Prof Johan F. Vansteenkiste summarises the results of the MAGRIT trial, a phase III trial which showed…
During a press conference at ESMO 2014, Dr Jean-Pascal Machiels, Cliniques Universitaires St. Luc, Brussels, Belgium, presents the results of…
During a press conference at ESMO 2014, Dr Bernardo Leon Rapoport, The Medical Oncology Centre Rosebank, Johannesburg, South Africa, presents…
During the Saturday press conference at ESMO 2014, Professor David Currow describes results of Phase III data showing that a…
Results of the MPACT Trial (weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone) in patients with metastatic pancreatic cancer will be…
The objective of this webinar was to provide an overview of the available front-line therapeutic options for patients with metastatic…
A study published online in the August 2014 edition of the Annals of Surgical Oncology shows that BluePrint (Agendia Inc)…